Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Zi Jie Long"'
Autor:
Ze-Wei Huang, Xue-Ning Zhang, Ling Zhang, Ling-Ling Liu, Jing-Wen Zhang, Yu-Xiang Sun, Jue-Qiong Xu, Quentin Liu, Zi-Jie Long
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-13 (2023)
Abstracts Immunotherapy is a revolutionized therapeutic strategy for tumor treatment attributing to the rapid development of genomics and immunology, and immune checkpoint inhibitors have successfully achieved responses in numbers of tumor types, inc
Externí odkaz:
https://doaj.org/article/2bb9b8ad17ca4dce91e2e77a5c77b708
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-16 (2023)
Abstract SOX1, a well-known tumor suppressor, delays malignant progression in most cancer types. However, high expression of SOX1 in late-stage head and neck squamous cell carcinoma leads to poor prognosis. In this study, we show that SOX1 induces na
Externí odkaz:
https://doaj.org/article/f4c243a4fc774577bb302b17f2005ada
Autor:
Zi-Jie Long, Jun-Dan Wang, Sheng-Xiang Qiu, Yi Zhang, Si-Jin Wu, Xin-Xing Lei, Ze-Wei Huang, Jia-Jie Chen, Yong-Liang Yang, Xiang-Zhong Zhang, Quentin Liu
Publikováno v:
Pharmacological Research, Vol 197, Iss , Pp 106973- (2023)
Immunogenic cell death (ICD), one of cell-death types through release of damage-associated molecular patterns from dying tumor cells, activates tumor-specific immune response and elicits anti-tumor immunity by traditional radiotherapy and chemotherap
Externí odkaz:
https://doaj.org/article/8e009f61426c4872a5c9d1fe29106570
Autor:
Jun-Dan Wang, Wei Zhang, Jing-Wen Zhang, Ling Zhang, Le-Xun Wang, Hong-Sheng Zhou, Liang Long, Gui Lu, Quentin Liu, Zi-Jie Long
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 491-503 (2020)
Acute myeloid leukemia (AML) mesenchymal stem cells (MSCs) play an essential role in protecting leukemic cells from chemotherapeutic agents through activating a wide range of adhesion molecules and cytokines. Thus, more attention should be paid to at
Externí odkaz:
https://doaj.org/article/ad3243f5968d48ff907c04a0c44fc7f1
Publikováno v:
Clinical and Translational Oncology. 25:1805-1820
Autor:
Quentin Liu, Dong-Jun Lin, Shao-Wu Wang, Jia-Jie Chen, Dong-Fan Xu, Min Yan, Zhi-Gang Fang, Fei-Meng Zheng, Le-Xun Wang, Zi-Jie Long, Ling-Ling Liu
PDF file - 82K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22aa57df51bd974dd0d65371382e689c
https://doi.org/10.1158/1541-7786.22509148.v1
https://doi.org/10.1158/1541-7786.22509148.v1
Autor:
Quentin Liu, Dong-Jun Lin, Shao-Wu Wang, Jia-Jie Chen, Dong-Fan Xu, Min Yan, Zhi-Gang Fang, Fei-Meng Zheng, Le-Xun Wang, Zi-Jie Long, Ling-Ling Liu
PDF file - 927K, The effect of Aurora kinases inhibitors on HL-60 and KG1a cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f76561bdbab13e38cb3c70f28319e981
https://doi.org/10.1158/1541-7786.22509172.v1
https://doi.org/10.1158/1541-7786.22509172.v1
Autor:
Quentin Liu, Dong-Jun Lin, Shao-Wu Wang, Jia-Jie Chen, Dong-Fan Xu, Min Yan, Zhi-Gang Fang, Fei-Meng Zheng, Le-Xun Wang, Zi-Jie Long, Ling-Ling Liu
PDF file - 1715K, Aurora kinases inhibitors and mTOR inhibitors had synergistic effect on the expression of cleaved caspase 3 and p62.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0250307f33c5b50410611a5ec1fdd506
https://doi.org/10.1158/1541-7786.22509154.v1
https://doi.org/10.1158/1541-7786.22509154.v1
Autor:
Quentin Liu, Dong-Jun Lin, Shao-Wu Wang, Jia-Jie Chen, Dong-Fan Xu, Min Yan, Zhi-Gang Fang, Fei-Meng Zheng, Le-Xun Wang, Zi-Jie Long, Ling-Ling Liu
PDF file - 1113K, Aurora kinases inhibitors had no effect with mTOR inhibitors on PBMCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dff38e7fa414f9786e1710bae53d303
https://doi.org/10.1158/1541-7786.22509157.v1
https://doi.org/10.1158/1541-7786.22509157.v1
Autor:
Quentin Liu, Dong-Jun Lin, Shao-Wu Wang, Jia-Jie Chen, Dong-Fan Xu, Min Yan, Zhi-Gang Fang, Fei-Meng Zheng, Le-Xun Wang, Zi-Jie Long, Ling-Ling Liu
PDF file - 1100K, Combination of Aurora kinases inhibitors and 2DG had minimal effect on PBMCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccf51609ed4743bee3ba7d5b86d7ba3
https://doi.org/10.1158/1541-7786.22509166.v1
https://doi.org/10.1158/1541-7786.22509166.v1